Aurora Cannabis Inc. Reminds Shareholders to Vote in Advance of the Proxy Voting Deadline for its 2024 Annual General and Special Meeting of Shareholders
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) is reminding shareholders to vote for its 2024 Annual General and Special Meeting, scheduled for August 9, 2024 at 1:00 p.m. Eastern Time. The proxy voting deadline is August 7, 2024 at 1:00 p.m. Eastern Time. The Board of Directors recommends voting FOR all director nominees and proposed resolutions.
Shareholders can attend the meeting via live webcast and are encouraged to review meeting materials available on Aurora's website and SEDAR+. For voting assistance, shareholders can contact Laurel Hill Advisory Group, Aurora's proxy solicitation agent. The company emphasizes that every vote is important, regardless of the number of shares owned.
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) ricorda agli azionisti di votare per l'Assemblea Generale Annuale e Straordinaria del 2024, programmata per il 9 agosto 2024 alle 13:00 ora orientale. La scadenza per il voto per delega è il 7 agosto 2024 alle 13:00 ora orientale. Il Consiglio di Amministrazione raccomanda di votare PER tutti i candidati alla carica di direttore e le risoluzioni proposte.
Gli azionisti possono partecipare all'incontro tramite webcast dal vivo e sono invitati a consultare il materiale dell'incontro disponibile sul sito web di Aurora e su SEDAR+. Per assistenza al voto, gli azionisti possono contattare il Laurel Hill Advisory Group, l'agente di sollecitazione per Aurora. L'azienda sottolinea che ogni voto è importante, indipendentemente dal numero di azioni possedute.
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) recuerda a los accionistas que voten en su Junta General y Especial Anual de 2024, programada para el 9 de agosto de 2024 a la 1:00 p.m. hora del Este. La fecha límite para la votación por poder es el 7 de agosto de 2024 a la 1:00 p.m. hora del Este. La Junta Directiva recomienda votar POR todos los candidatos a director y las resoluciones propuestas.
Los accionistas pueden asistir a la reunión a través de una transmisión en vivo y se les anima a revisar los materiales de la reunión disponibles en el sitio web de Aurora y en SEDAR+. Para asistencia con la votación, los accionistas pueden contactar al Laurel Hill Advisory Group, el agente de solicitud de poderes de Aurora. La empresa enfatiza que cada voto es importante, sin importar la cantidad de acciones que se posean.
오로라 칸나비스 Inc. (NASDAQ: ACB) (TSX: ACB)는 주주들에게 2024년 정기 총회 및 특별 총회에 투표할 것을 상기시키고 있습니다. 회의는 2024년 8월 9일 동부 표준시 기준으로 오후 1시에 예정되어 있습니다. 대리 투표 마감일은 2024년 8월 7일 동부 표준시 기준으로 오후 1시입니다. 이사회는 모든 이사 후보 및 제안된 결의안에 대해 찬성 투표할 것을 권장합니다.
주주들은 라이브 웹캐스트를 통해 회의에 참석할 수 있으며, 오로라의 웹사이트와 SEDAR+에서 회의 자료를 검토할 것을 권장합니다. 투표 지원이 필요한 경우 주주들은 오로라의 대리투표 요청 에이전트인 로렐 힐 어드바이저리 그룹에 연락할 수 있습니다. 회사는 소유한 주식 수에 관계없이 모든 투표가 중요하다고 강조합니다.
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) rappelle aux actionnaires de voter pour son Assemblée Générale Annuelle et Extraordinaire de 2024, prévue le 9 août 2024 à 13h00, heure de l'Est. La date limite pour le vote par procuration est le 7 août 2024 à 13h00, heure de l'Est. Le Conseil d'Administration recommande de voter POUR tous les candidats au poste de directeur et les résolutions proposées.
Les actionnaires peuvent assister à la réunion en direct par webdiffusion et sont encouragés à consulter les documents de réunion disponibles sur le site Web d'Aurora et SEDAR+. Pour toute assistance au vote, les actionnaires peuvent contacter le Laurel Hill Advisory Group, l'agent de sollicitation des procurations d'Aurora. L'entreprise souligne que chaque vote est important, quelle que soit le nombre d'actions détenues.
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) erinnert die Aktionäre daran, für die jährliche Haupt- und Sonderversammlung 2024 zu stimmen, die für den 9. August 2024 um 13:00 Uhr Eastern Time geplant ist. Die Frist für die Stimmabgabe per Vollmacht ist der 7. August 2024 um 13:00 Uhr Eastern Time. Der Vorstand empfiehlt, für alle vorgeschlagenen Direktoren und Beschlüsse zu stimmen.
Die Aktionäre können an der Sitzung über einen Webcast in Echtzeit teilnehmen und werden ermutigt, die Versammlungsunterlagen auf Auroras Website und SEDAR+ zu überprüfen. Bei Fragen zur Stimmabgabe können Aktionäre die Laurel Hill Advisory Group, den Stellvertreter von Aurora, kontaktieren. Das Unternehmen betont, dass jede Stimme wichtig ist, unabhängig von der Anzahl der gehaltenen Aktien.
- None.
- None.
NASDAQ | TSX: ACB
Your vote is important no matter how many shares you own. Please vote today.
Shareholders with questions or who need assistance voting their shares should contact Aurora's strategic advisor and
proxy solicitation agent, Laurel Hill Advisory Group (Toll-Free Tel: 1-877-452-7184 / International Tel: 1-416-304-0211
E-mail: assistance@laurelhill.com)
Shareholders are advised to vote their shares well in advance of the proxy voting deadline of Wednesday August 7, 2024 at 1:00 p.m. Eastern Time / 11:00 a.m. Mountain Time.
YOUR VOTE IS IMPORTANT NO MATTER HOW MANY SHARES YOU HOLD
THE BOARD OF DIRECTORS RECOMMENDS THAT SHAREHOLDERS VOTE FOR ALL DIRECTOR NOMINEES AND PROPOSED RESOLUTIONS
Shareholders are encouraged to read the Meeting materials, available on the Company's website at www.auroramj.com/investors/corporate-governance as well as under Aurora's profile on SEDAR+ (www.sedarplus.ca). In the interest of time, shareholders may vote online or by telephone in accordance with the voting instructions found on their form of proxy or voting instruction form.
Shareholder Questions or Voting Assistance: Shareholders who have questions or require assistance with voting may contact the Aurora's proxy solicitation agent and shareholder communications advisor:
Laurel Hill Advisory Group
Toll Free: 1-877-452-7184 (for shareholders in
International: +1 416-304-0211 (for shareholders outside
Email: assistance@laurelhill.com
About Aurora
Aurora is opening the world to cannabis, serving both the medical and consumer markets across
Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB".
Forward Looking Statements
This news release includes statements containing certain "forward looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include statements regarding the Meeting, including the time and how to participate.
These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and nongovernment consumer sales channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration of acquired business and operations, management's estimation that SG&A will grow only in proportion of revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises, and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information form dated June 20, 2024 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR at www.sedarplus.com and filed with and available on the SEC's website at www.sec.gov. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.
View original content to download multimedia:https://www.prnewswire.com/news-releases/aurora-cannabis-inc-reminds-shareholders-to-vote-in-advance-of-the-proxy-voting-deadline-for-its-2024-annual-general-and-special-meeting-of-shareholders-302209444.html
SOURCE Aurora Cannabis Inc.
FAQ
When is Aurora Cannabis (ACB) holding its 2024 Annual General and Special Meeting?
What is the proxy voting deadline for Aurora Cannabis (ACB) 2024 Annual Meeting?
How can shareholders access Aurora Cannabis (ACB) 2024 Annual Meeting materials?
Who should shareholders contact for voting assistance for Aurora Cannabis (ACB) 2024 Annual Meeting?
What does the Board of Directors recommend for Aurora Cannabis (ACB) 2024 Annual Meeting voting?
